Viewing Study NCT00460460


Ignite Creation Date: 2025-12-25 @ 2:12 AM
Ignite Modification Date: 2026-01-08 @ 6:53 AM
Study NCT ID: NCT00460460
Status: TERMINATED
Last Update Posted: 2011-01-25
First Post: 2007-04-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module